Navigation Links
GeoVax Labs' CEO Update Letter to Shareholders
Date:1/9/2012

ATLANTA, Jan. 9, 2012 /PRNewswire/ -- Robert McNally, Ph.D., President and CEO of GeoVax Labs, Inc. (OTCQB/OTCBB: GOVX), today issued the following letter to shareholders:

Dear Fellow Shareholders,

At the start of a new year, it is important to acknowledge all that we have accomplished over the past year, but it is even more crucial to focus our energies on the challenges and opportunities awaiting GeoVax in 2012 and beyond.

Here is a recap of our recent achievements, which have put the company on course for a very successful future. During 2011, GeoVax achieved steady progress in developing our HIV/AIDS vaccines and continued to lay a solid foundation for continued clinical and corporate success. While we are pleased with our results, our goal for 2012 is to achieve even greater and more timely progress.

Therapeutic Vaccine Program

We continue to make progress in our Phase 1/2 clinical trial for our HIV/AIDS therapeutic vaccine. The primary goals of the trial are to document the safety and immunogenicity (e.g., "immune response") of the vaccine in HIV-diagnosed patients with well-controlled infections. To accelerate enrollment in the trial, we added two clinical sites, the University of Alabama, Birmingham and the AIDS Research Alliance in Los Angeles. These sites join our initial site in Atlanta that is being run by ARCA (AIDS Research Consortium of Atlanta). In December, we announced inoculation of the first participant in this clinical program. Our goal is to have full enrollment by the end of 2012 and to be generating meaningful data in 2013. If the data are encouraging, this program will likely be expanded into a larger Phase 2 clinical trial. The successful application of our vaccine among already infected patients would represent a significant addition, and potential alternative, to the current antiviral drug therapy that is required for the remainder of a patient's life. Current estimates of the
'/>"/>

SOURCE GeoVax Labs, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. GeoVax Labs First Patient Inoculated in Phase 1/2 Clinical Trial for HIV/AIDS Therapeutic Vaccine
2. GeoVax Phase 2a Clinical Trial Completes Enrollment
3. GeoVax $3.6 Million Award Increased to $4.4 Million by U.S. Government
4. GeoVax Labs, Inc. Announces Second Quarter Financial Results
5. GeoVax Labs HIV/AIDS Vaccine Development Leadership to be Highlighted During 2011 World Vaccine Congress
6. GeoVax Announces Publication of Phase 1 Clinical Trial in The Journal of Infectious Diseases
7. GeoVax Launches a Second Clinical Site to Test the Therapeutic Benefit of its HIV Vaccine
8. David A. Dodd Appointed Chairman of the Board of GeoVax Labs
9. GeoVax Announces Expansion of Phase 2a Human HIV/AIDS Vaccine Trial
10. GeoVax Awarded Federal Grant Under the Qualifying Therapeutic Discovery Project Program
11. GeoVax Labs Engages The Investor Relations Group
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2014)... YORK , Sept. 17, 2014  Levi & ... in connection with possible claims of breaches of fiduciary ... To get more information, click here: ... you. If you own common stock in ... please contact Eduard Korsinsky, Esq. either via ...
(Date:9/17/2014)... , Sept. 17, 2014 /PRNewswire-iReach/ -- ... white paper discussing improvements in the development ... structures for both normal and diseased tissue ... information, simplifies surgical procedures, lowers surgical costs ... surgical procedures. The clinical ...
(Date:9/17/2014)... , Sept. 17, 2014 Bronstein, Gewirtz & ... purchasers of the securities of PDL BioPharma, Inc. ("PDL ... -News).  Such investors are advised to contact Peretz ... Kimelman at info@bgandg.com or 212-697-6484. ... certain of its executives violated federal securities laws. ...
Breaking Medicine Technology:Patient Outcomes Improve When Molecular Chemical Imaging Technology Is Used to Aid Robotic Surgical Procedures, According to New White Paper 2Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Investigates claims on behalf of Investors of PDL BioPharma, Inc. --PDLI 2
(Date:9/17/2014)... 2014 The National Resident Matching Program ... a comprehensive analysis of the relationship between unique applicant ... The new edition is based on the 2014 ... U.S. allopathic medical school senior students and all other ... to provide this new edition of Charting Outcomes in ...
(Date:9/17/2014)... Los Angeles, CA (PRWEB) September 17, 2014 ... U.S. Food & Drug Administration report titled “Adverse ... Intranasal Splint as a Dermal Filler,” unapproved use ... filler injections has resulted in adverse reactions including ... acid based products with FDA approval for cosmetic ...
(Date:9/17/2014)... 17, 2014 Sunday night saw ... and ushered in a new national spokesperson for ... America Organization’s official national platform, Children’s Miracle ... newest National Goodwill Ambassador. , Kazantsev’s year in ... Network Hospitals across the U.S., visiting with patients ...
(Date:9/17/2014)... study was announced today that will analyze how ... wellness and contribute to healthy aging. , ... funded through a $10 million unrestricted gift from ... aims to identify lifestyle and environmental factors that ... as they age. WELL will be designed, conducted, ...
(Date:9/17/2014)... (HealthDay News) -- Social networking sites can help people ... people who are obese, sites like Twitter and Facebook ... from doctors as well as peers, researchers found. ... is that it offers the potential to be much ... compared to traditional approaches," the study,s lead author, Dr. ...
Breaking Medicine News(10 mins):Health News:Just Released: Charting Outcomes in the Match for the 2014 Main Residency Match® 2Health News:Just Released: Charting Outcomes in the Match for the 2014 Main Residency Match® 3Health News:Simon Ourian, Kim Kardashian's Cosmetic Surgeon, Warns About Illegal Use of Expression as a Dermal Filler 2Health News:Miss America 2015 Kira Kazantsev Takes On Role as Children’s Miracle Network Hospitals National Goodwill Ambassador 2Health News:Miss America 2015 Kira Kazantsev Takes On Role as Children’s Miracle Network Hospitals National Goodwill Ambassador 3Health News:First-ever research study examines impacts of diet and lifestyle on healthy aging 2Health News:Social Networking Sites Can Help Obese Lose Weight: Study 2
... ST. PAUL / MINNEAPOLIS (April 29, 2008) Young ... sexual partners both online and offline have greater numbers of partners, ... rates than those who meet their partners exclusively online or offline, ... ...
... return of members, money to UHW-W,treasury from outside fund, ... local union United Healthcare Workers West (UHW-W) violated federal,law ... millions,of dollars in dues money to an outside fund ... today by SEIU in United States District,Court for the ...
... opportunities for buyer to, capitalize on ... YORK, April 29 Berkery Noyes announced today ... sale to HMP,Communications, a portfolio company of Alta ... investment in the new combined entity. Terms,of the ...
... levels increasing even within normal range associated with dangers ... of thyrotropin within the normal range may increase the ... Norwegian study finds. , Thyrotropin, a hormone produced by ... acts on the thyroid gland to stimulate its growth ...
... (ACP) -- the nations second-largest medical society , ... a continuing medical education (CME) meeting for general ... primary and subspecialty care to adult patients. More ... professionals, medical residents, fellows, and students. Internal Medicine ...
... Baptist Health System, one,of Alabama,s largest healthcare ... to bring together the health-improvement,needs of local employers ... its four hospitals. Aegis brings nearly 20 years, ... with the unique,healthcare needs of area employees., ...
Cached Medicine News:Health News:U of M study: Online intervention paramount for reducing HIV in high-risk population 2Health News:Top UHW-W Officers Violated Federal Law, Deceived Members in Diverting Millions in Dues Money to Outside Fund 2Health News:Top UHW-W Officers Violated Federal Law, Deceived Members in Diverting Millions in Dues Money to Outside Fund 3Health News:Top UHW-W Officers Violated Federal Law, Deceived Members in Diverting Millions in Dues Money to Outside Fund 4Health News:Berkery Noyes Represents Princeton Media Associates in Its Sale to HMP Communications/Alta 2Health News:Berkery Noyes Represents Princeton Media Associates in Its Sale to HMP Communications/Alta 3Health News:Pituitary Hormone May Boost Women's Heart Risk 2Health News:Internal Medicine 2008 media advisory 2Health News:Alabama's Baptist Health System and Aegis Health Group Partner to Address Local Employers Health-Management Concerns 2
The Eppendorf Maxipettor is a continuously adjustable pipette for precise pipetting of volumes up to 10 ml (in 10 l increments). Even liquids with a high vapor pressure or viscosity can be pipetted w...
... The Repeater Plus, a handheld manual ... saving time on long series pipetting. Its ... exceptional support for research tasks, and its ... with repetitive work. The nine Combitips allow ...
eValuator fixed-curve diagnostic electrophysiology catheters offer an effective balance between clinical performance and cost....
The True Non-Compliant Balloon....
Medicine Products: